Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer
Sponsor: Xijing Hospital
Summary
A total of 340 early-stage breast cancer patients with axillary lymph node biopsy-confirmed positivity were enrolled and divided into two groups. The control group received neoadjuvant systemic therapy followed by surgery and adjuvant radiotherapy. The experimental group received neoadjuvant systemic therapy and neoadjuvant radiotherapy followed by surgery. The treatment response of breast cancer, patient survival time, and treatment safety were subsequently evaluated.
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
340
Start Date
2024-12-31
Completion Date
2031-12-31
Last Updated
2025-01-10
Healthy Volunteers
No
Conditions
Interventions
Neoadjuvant radiotherapy
The experimental group will receive neoadjuvant systemic therapy combined with neoadjuvant radiotherapy before undergoing surgery
Locations (1)
Xijing hospital
Xi'an, Shaanxi, China